Skip to main content
. 2016 Sep 6;34(32):3854–3863. doi: 10.1200/JCO.2016.68.1239

Fig A2.

Fig A2.

Sensitivity analysis including patients who received intraperitoneal and intravenous chemotherapy: Kaplan-Meier survival plots within propensity-score matched samples. (A) Stage IIIC disease. (B) Stage IV disease. NACT, neoadjuvant chemotherapy; PCS, primary cytoreductive surgery.